NasdaqCM - Delayed Quote USD

Purple Biotech Ltd (PPBT)

2.2050
-0.0150
(-0.68%)
At close: May 9 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
10,803
10,803
22,271
22,603
17,934
Operating Income
-10,803
-10,803
-22,271
-22,603
-17,934
Net Non Operating Interest Income Expense
-212
-212
-1,707
536
241
Other Income Expense
3,736
3,736
4,001
307
-133
Pretax Income
-7,279
-7,279
-19,977
-21,760
-17,826
Tax Provision
--
--
--
--
0
Net Income Common Stockholders
-7,240
-7,240
-19,880
-21,668
-18,384
Diluted NI Available to Com Stockholders
-7,240
-7,240
-19,880
-21,668
-18,384
Basic EPS
-44.16
-44.16
-17.96
-23.97
-21.00
Diluted EPS
-49.90
-49.90
-17.96
-23.97
-21.00
Basic Average Shares
163.9570
163.9570
1,106.6650
904.0540
878.4020
Diluted Average Shares
163.9790
163.9790
1,106.6650
904.0540
878.4020
Total Operating Income as Reported
-11,005
-11,005
-22,271
-22,603
-17,934
Total Expenses
10,803
10,803
22,271
22,603
17,934
Net Income from Continuing & Discontinued Operation
-7,240
-7,240
-19,880
-21,668
-18,384
Normalized Income
-10,976
-10,976
-23,881
-21,975
-17,609
Interest Income
260
260
474
532
320
Interest Expense
41
41
56
67
79
Net Interest Income
-212
-212
-1,707
536
241
EBIT
-7,238
-7,238
-19,921
-21,693
-17,747
EBITDA
-7,052
-7,052
-19,724
-21,492
-17,516
Reconciled Depreciation
186
186
197
201
231
Net Income from Continuing Operation Net Minority Interest
-7,240
-7,240
-19,880
-21,668
-17,742
Total Unusual Items Excluding Goodwill
3,736
3,736
4,001
307
-133
Total Unusual Items
3,736
3,736
4,001
307
-133
Normalized EBITDA
-10,788
-10,788
-23,725
-21,799
-17,383
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/20/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EVGN Evogene Ltd.
1.1325
+0.22%
 
CANF Can-Fite BioPharma Ltd.
1.1100
-0.45%
 
CYCN Cyclerion Therapeutics, Inc.
3.2784
+4.74%
 
BCLI Brainstorm Cell Therapeutics Inc.
1.1800
-3.28%
 
SNTI Senti Biosciences, Inc.
3.2600
-1.51%
 
XTLB XTL Biopharmaceuticals Ltd.
1.2600
+1.61%
 
FBRX Forte Biosciences, Inc.
6.38
+2.41%
 
ENLV Enlivex Therapeutics Ltd.
1.0200
-2.86%
 
CGEN Compugen Ltd.
1.2600
-2.33%
 
OSRH OSR Holdings, Inc.
1.2500
-2.34%